Carbenicillin Disodium

CHEMBL606260 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

422.4 g/mol

LogP

—

Phase

4

The disodium salt of carbenicillin, formulated for intravenous or intramuscular injection to treat serious infections caused by Pseudomonas and other susceptible gram-negative bacteria. Like carbenicillin, it disrupts bacterial cell wall construction. It has largely been superseded by newer extended-spectrum penicillins and other beta-lactam antibiotics.

Molekularmasse

422,4000 g/mol

TPSA

155,00 Å²

Wirkmechanismus

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mechanismus

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell …

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)[O-])c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]

InChI

InChI=1S/C17H18N2O6S.2Na/c1-17(2)11(16(24)25)19-13(21)10(14(19)26-17)18-12(20)9(15(22)23)8-6-4-3-5-7-8;;/h3-7,9-11,14H,1-2H3,(H,18,20)(H,22,23)(H,24,25);;/q;2*+1/p-2/t9?,10-,11+,14-;;/m1../s1

Molecular Formula

C17H16N2Na2O6S

HBD / HBA

1 / 7

Rotierbare Bindungen

3

Schwere Atome

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

The disodium salt of carbenicillin, formulated for intravenous or intramuscular injection to treat serious infections caused by Pseudomonas and other susceptible gram-negative bacteria. Like carbenicillin, it disrupts bacterial cell wall construction. It has largely been superseded by newer extended-spectrum penicillins and other beta-lactam antibiotics.

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Yes, Carbenicillin Disodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL606260. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 20933. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Carbenicillin Disodium auf PillFYI

Struktur

Schnelldaten

Formel: C17H16N2Na2O6S

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.